Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 28, 2008American Journal of TransplantationOpen Access

Mammalian Target of Rapamycin Inhibitor Dyslipidemia in Kidney Transplant Recipients

View Full Paper
Ask AI
Bookmark
Share

Authors

BKBertram L. KasiskeUniversity of CopenhagenAMAngelo de MattosOregon Health & Science UniversitySFStuart M. FlechnerCleveland Clinic Lerner College of Medicine

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kasiske et al. (2008) studied this question.

synapsesocial.com/papers/6a8344583019910892ae340fhttps://doi.org/10.1111/j.1600-6143.2008.02272.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sirolimus Modifies Cholesterol Homeostasis in Hepatic Cells: A Potential Molecular Mechanism for Sirolimus-Associated Dyslipidemia2007 · 46 citations
  2. 2Effects of sirolimus on mesangial cell cholesterol homeostasis: a novel mechanism for its action against lipid-mediated injury in renal allografts2005 · 26 citations
  3. 3MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial2002 · 7,042 citations
  4. 4Three‐Year Efficacy and Safety Results from a Study of Everolimus Versus Mycophenolate Mofetil in de novo Renal Transplant Patients2005 · 218 citations
  5. 5The Unique Character of Cardiovascular Disease in Chronic Kidney Disease and Its Implications for Treatment with Lipid-Lowering Drugs2007 · 34 citations